Yingfang Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yingfang Tian has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Glen C. Jickling
Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada
7 shared publications Dazhi Liu
Departments of Neurology, and the MIND Institute, University of California at Davis, Sacramento, California USA 95817
4 shared publicationsFrank R. Sharp
Departments of Neurology, and the MIND Institute, University of California at Davis, Sacramento, California USA 95817
4 shared publicationsBoryana Stamova
Departments of Neurology, and the MIND Institute, University of California at Davis, Sacramento, California USA 95817
3 shared publicationsBradley P. Ander
Departments of Neurology, and the MIND Institute, University of California at Davis, Sacramento, California USA 95817
3 shared publications- Renee Jade Turner
School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia
3 shared publications
Latest Publications
- 1 April 2012
- Published by Elsevier in Gender Medicine
- Vol. 9 (2) , 68-75.e3
Y Chromosome Gene Expression in the Blood of Male Patients With Ischemic Stroke Compared With Male Controls
- 1 April 2012
- Published by Elsevier in Gender Medicine
- Vol. 9 (2) , 68-75.e3
Y Chromosome Gene Expression in the Blood of Male Patients With Ischemic Stroke Compared With Male Controls
- 14 December 2011
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 32 (5) , 780-791
Effects of Gender on Gene Expression in the Blood of Ischemic Stroke Patients
This study examined the effects of gender on RNA expression after ischemic stroke (IS). RNA obtained from blood of IS patients ( n = 51; 153 samples at ≤ 3, 5, and 24 hours) and from matched controls ( n = 52) were processed on Affymetrix microarrays. Analyses of covariance for stroke versus control samples were performed separately for both genders and the regulated genes for females compared with males. In all, 242, 227, and 338 male-specific genes were regulated at ≤ 3, 5, and 24 hours after IS, respectively, of which 59 were regulated at all time points. Overall, 774, 3,437, and 571 female-specific stroke genes were regulated at ≤ 3, 5, and 24 hours, respectively, of which 152 were regulated at all time points. Male-specific stroke genes were associated with integrin, integrin-liked kinase, actin, tight junction, Wnt/β-catenin, RhoA, fibroblast growth factors (FGF), granzyme, and tumor necrosis factor receptor (TNFR)2 signaling. Female-specific stroke genes were associated with p53, high-mobility group box-1, hypoxia inducible factor (HIF)1α, interleukin (IL)1, IL6, IL12, IL18, acute-phase response, T-helper, macrophage, and estrogen signaling. Cell death signaling was overrepresented in both genders, although the molecules and pathways differed. Gender affects gene expression in the blood of IS patients, which likely implies gender differences in immune, inflammatory, and cell death responses to stroke.
- 14 December 2011
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 32 (5) , 780-791
Effects of Gender on Gene Expression in the Blood of Ischemic Stroke Patients
This study examined the effects of gender on RNA expression after ischemic stroke (IS). RNA obtained from blood of IS patients ( n = 51; 153 samples at ≤ 3, 5, and 24 hours) and from matched controls ( n = 52) were processed on Affymetrix microarrays. Analyses of covariance for stroke versus control samples were performed separately for both genders and the regulated genes for females compared with males. In all, 242, 227, and 338 male-specific genes were regulated at ≤ 3, 5, and 24 hours after IS, respectively, of which 59 were regulated at all time points. Overall, 774, 3,437, and 571 female-specific stroke genes were regulated at ≤ 3, 5, and 24 hours, respectively, of which 152 were regulated at all time points. Male-specific stroke genes were associated with integrin, integrin-liked kinase, actin, tight junction, Wnt/β-catenin, RhoA, fibroblast growth factors (FGF), granzyme, and tumor necrosis factor receptor (TNFR)2 signaling. Female-specific stroke genes were associated with p53, high-mobility group box-1, hypoxia inducible factor (HIF)1α, interleukin (IL)1, IL6, IL12, IL18, acute-phase response, T-helper, macrophage, and estrogen signaling. Cell death signaling was overrepresented in both genders, although the molecules and pathways differed. Gender affects gene expression in the blood of IS patients, which likely implies gender differences in immune, inflammatory, and cell death responses to stroke.
- 17 November 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 156 (1) , 72-78
Exon expression and alternatively spliced genes in tourette syndrome
Tourette Syndrome (TS) is diagnosed based upon clinical criteria including motor and vocal tics. We hypothesized that differences in exon expression and splicing might be useful for pathophysiology and diagnosis. To demonstrate exon expression and alternatively spliced gene differences in blood of individuals with TS compared to healthy controls (HC), RNA was isolated from the blood of 26 un‐medicated TS subjects and 23 HC. Each sample was run on Affymetrix Human Exon 1.0 ST (HuExon) arrays and on 3′ biased U133 Plus 2.0 (HuU133) arrays. To investigate the differentially expressed exons and transcripts, analyses of covariance (ANCOVA) were performed, controlling for age, gender, and batch. Differential alternative splicing patterns between TS and HC were identified using analyses of variance (ANOVA) models in Partek. Three hundred and seventy‐six exon probe sets were differentially expressed between TS and HC (rawP < 0.005, fold change >|1.2|) that separated TS and HC subjects using hierarchical clustering and Principal Components Analysis. The probe sets predicted TS compared to HC with a >90% sensitivity and specificity using a 10‐fold cross‐validation. Ninety genes (transcripts) had differential expression of a single exon (rawP < 0.005) and were predicted to be alternatively spliced (rawP < 0.05) in TS compared to HC. These preliminary findings might provide insight into the pathophysiology of TS and potentially provide prognostic and diagnostic biomarkers. However, the findings are tempered by the small sample size and multiple comparisons and require confirmation using PCR or deep RNA sequencing and a much larger patient population.
- 17 November 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 156 (1) , 72-78
Exon expression and alternatively spliced genes in tourette syndrome
Tourette Syndrome (TS) is diagnosed based upon clinical criteria including motor and vocal tics. We hypothesized that differences in exon expression and splicing might be useful for pathophysiology and diagnosis. To demonstrate exon expression and alternatively spliced gene differences in blood of individuals with TS compared to healthy controls (HC), RNA was isolated from the blood of 26 un‐medicated TS subjects and 23 HC. Each sample was run on Affymetrix Human Exon 1.0 ST (HuExon) arrays and on 3′ biased U133 Plus 2.0 (HuU133) arrays. To investigate the differentially expressed exons and transcripts, analyses of covariance (ANCOVA) were performed, controlling for age, gender, and batch. Differential alternative splicing patterns between TS and HC were identified using analyses of variance (ANOVA) models in Partek. Three hundred and seventy‐six exon probe sets were differentially expressed between TS and HC (rawP < 0.005, fold change >|1.2|) that separated TS and HC subjects using hierarchical clustering and Principal Components Analysis. The probe sets predicted TS compared to HC with a >90% sensitivity and specificity using a 10‐fold cross‐validation. Ninety genes (transcripts) had differential expression of a single exon (rawP < 0.005) and were predicted to be alternatively spliced (rawP < 0.05) in TS compared to HC. These preliminary findings might provide insight into the pathophysiology of TS and potentially provide prognostic and diagnostic biomarkers. However, the findings are tempered by the small sample size and multiple comparisons and require confirmation using PCR or deep RNA sequencing and a much larger patient population.
- 4 October 2010
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 230 (1-2) , 124-129
Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects
- 4 October 2010
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 230 (1-2) , 124-129
Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects
- Open Access
- 1 January 2010
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 254
Genome response to tissue plasminogen activator in experimental ischemic stroke
Tissue plasminogen activator (tPA) is known to have functions beyond fibrinolysis in acute ischemic stroke, such as blood brain barrier disruption. To further delineate tPA functions in the blood, we examined the gene expression profiles induced by tPA in a rat model of ischemic stroke.
- 1 January 2010
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 254
Open AccessGenome response to tissue plasminogen activator in experimental ischemic stroke
Tissue plasminogen activator (tPA) is known to have functions beyond fibrinolysis in acute ischemic stroke, such as blood brain barrier disruption. To further delineate tPA functions in the blood, we examined the gene expression profiles induced by tPA in a rat model of ischemic stroke.
- Open Access
- 17 November 2009
- Published by Springer Nature in Neurotoxicity Research
- Vol. 19 (1) , 1-13
Correlations of Gene Expression with Blood Lead Levels in Children with Autism Compared to Typically Developing Controls
The objective of this study was to examine the correlation between gene expression and lead (Pb) levels in blood in children with autism (AU, n = 37) compared to typically developing controls (TD, n = 15). We postulated that, though lead levels did not differ between the groups, AU children might metabolize lead differently compared to TD children. RNA was isolated from blood and processed on Affymetrix microarrays. Separate analyses of covariance (ANCOVA) corrected for age and gender were performed for TD, AU, and all subjects (AU + TD). To reduce false positives, only genes that overlapped these three ANCOVAs were considered. Thus, 48 probe sets correlated with lead levels in both AU and TD subjects and were significantly different between the groups (p(Diagnosis × log2 Pb) < 0.05). These genes were related mainly to immune and inflammatory processes, including MHC Class II family members and CD74. A large number (n = 791) of probe sets correlated (P ≤ 0.05) with lead levels in TD but not in AU subjects; and many probe sets (n = 162) correlated (P ≤ 0.05) with lead levels in AU but not in TD subjects. Only 30 probe sets correlated (P ≤ 0.05) with lead levels in a similar manner in the AU and TD groups. These data show that AU and TD children display different associations between transcript levels and low levels of lead. We postulate that this may relate to the underlying genetic differences between the two groups, though other explanations cannot be excluded.
- 17 November 2009
- Published by Springer Nature in Neurotoxicity Research
- Vol. 19 (1) , 1-13
Open AccessCorrelations of Gene Expression with Blood Lead Levels in Children with Autism Compared to Typically Developing Controls
The objective of this study was to examine the correlation between gene expression and lead (Pb) levels in blood in children with autism (AU, n = 37) compared to typically developing controls (TD, n = 15). We postulated that, though lead levels did not differ between the groups, AU children might metabolize lead differently compared to TD children. RNA was isolated from blood and processed on Affymetrix microarrays. Separate analyses of covariance (ANCOVA) corrected for age and gender were performed for TD, AU, and all subjects (AU + TD). To reduce false positives, only genes that overlapped these three ANCOVAs were considered. Thus, 48 probe sets correlated with lead levels in both AU and TD subjects and were significantly different between the groups (p(Diagnosis × log2 Pb) < 0.05). These genes were related mainly to immune and inflammatory processes, including MHC Class II family members and CD74. A large number (n = 791) of probe sets correlated (P ≤ 0.05) with lead levels in TD but not in AU subjects; and many probe sets (n = 162) correlated (P ≤ 0.05) with lead levels in AU but not in TD subjects. Only 30 probe sets correlated (P ≤ 0.05) with lead levels in a similar manner in the AU and TD groups. These data show that AU and TD children display different associations between transcript levels and low levels of lead. We postulate that this may relate to the underlying genetic differences between the two groups, though other explanations cannot be excluded.
- Open Access
- 5 August 2009
- Published by Springer Nature in BMC Medical Genomics
- Vol. 2 (1) , 49
Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood
Gene expression studies require appropriate normalization methods. One such method uses stably expressed reference genes. Since suitable reference genes appear to be unique for each tissue, we have identified an optimal set of the most stably expressed genes in human blood that can be used for normalization.
- 5 August 2009
- Published by Springer Nature in BMC Medical Genomics
- Vol. 2 (1) , 49
Open AccessIdentification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood
Gene expression studies require appropriate normalization methods. One such method uses stably expressed reference genes. Since suitable reference genes appear to be unique for each tissue, we have identified an optimal set of the most stably expressed genes in human blood that can be used for normalization.